share_log
Benzinga ·  Apr 30 12:14
Eli Lilly Says Proposed U.S. BIOSECURE Act Would Affect Pharmaceutical Supply Chain Elements; Currently Do Not See It To Have Material Impact On Business
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment